Tran, D., Warren, S., Allen, A., Sampson, D., Chen, D., Thomas, N., . . . Ghiaseddin, A. (2019). ATIM-39. PHASE 2 OPEN-LABELED STUDY OF ADJUVANT TEMOZOLOMIDE PLUS TUMOR TREATING FIELDS PLUS PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP). Neuro Oncol.
استشهاد بنمط شيكاغوTran, David, Sonisha Warren, Anne Allen, Deborah Sampson, Dongjiang Chen, Nagheme Thomas, Valerie Greene, Maryam Rahman, و Ashley Ghiaseddin. "ATIM-39. PHASE 2 OPEN-LABELED STUDY OF ADJUVANT TEMOZOLOMIDE PLUS TUMOR TREATING FIELDS PLUS PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP)." Neuro Oncol 2019.
MLA استشهادTran, David, et al. "ATIM-39. PHASE 2 OPEN-LABELED STUDY OF ADJUVANT TEMOZOLOMIDE PLUS TUMOR TREATING FIELDS PLUS PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP)." Neuro Oncol 2019.